These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 17596616

  • 1. Rituximab in patients with the steroid-resistant nephrotic syndrome.
    Bagga A, Sinha A, Moudgil A.
    N Engl J Med; 2007 Jun 28; 356(26):2751-2. PubMed ID: 17596616
    [No Abstract] [Full Text] [Related]

  • 2. Ofatumumab for rituximab-resistant nephrotic syndrome.
    Basu B.
    N Engl J Med; 2014 Mar 27; 370(13):1268-70. PubMed ID: 24670185
    [No Abstract] [Full Text] [Related]

  • 3. [Idiopathic nephrotic syndrome in children: from corticosteroids to rituximab].
    Deschênes G.
    Arch Pediatr; 2011 Aug 27; 18(8):843-5. PubMed ID: 21719260
    [No Abstract] [Full Text] [Related]

  • 4. Life threatening steroid-resistant autoimmune anemia successfully treated with rituximab: a case report.
    Noel N, Monnet X, Angel N, Goujard C, Lambotte O.
    Am J Hematol; 2009 Mar 27; 84(3):193. PubMed ID: 19140188
    [No Abstract] [Full Text] [Related]

  • 5. [Results of the treatment of steroid-resistant and steroid-dependent nephrotic syndrome with pulsed doses of prednisolone].
    Gura C, Pałka L, Pańczyk-Tomaszewska M, Sieniawska M, Pazdur J.
    Wiad Lek; 1992 May 27; 45(9-10):343-8. PubMed ID: 1441541
    [Abstract] [Full Text] [Related]

  • 6. Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome.
    Kurosu N, Sugiura H, Iwasaki C, Asamiya Y, Kojima C, Moriyama T, Itabashi M, Tsukada M, Takei T, Ogawa T, Yoshida T, Uchida K, Tsuchiya K, Nitta K.
    Intern Med; 2009 May 27; 48(21):1901-4. PubMed ID: 19881243
    [Abstract] [Full Text] [Related]

  • 7. Rituximab in The Management of Pediatric Steroid-Resistant Nephrotic Syndrome: A Systematic Review.
    Jellouli M, Charfi R, Maalej B, Mahfoud A, Trabelsi S, Gargah T.
    J Pediatr; 2018 Jun 27; 197():191-197.e1. PubMed ID: 29680473
    [Abstract] [Full Text] [Related]

  • 8. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R, de Jong M, Monnens L.
    Ned Tijdschr Geneeskd; 1992 May 02; 136(18):876-80. PubMed ID: 1589052
    [Abstract] [Full Text] [Related]

  • 9. Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.
    Ravani P, Bonanni A, Rossi R, Caridi G, Ghiggeri GM.
    Clin J Am Soc Nephrol; 2016 Apr 07; 11(4):710-20. PubMed ID: 26585985
    [Abstract] [Full Text] [Related]

  • 10. Rituximab and nephrotic syndrome: a new therapeutic hope?
    Ahmed MS, Wong CF.
    Nephrol Dial Transplant; 2008 Jan 07; 23(1):11-7. PubMed ID: 18065825
    [No Abstract] [Full Text] [Related]

  • 11. [New treatments for Idiopathic Nephrotic Syndrome].
    Guigonis V.
    Arch Pediatr; 2009 Jun 07; 16(6):802-4. PubMed ID: 19541177
    [No Abstract] [Full Text] [Related]

  • 12. Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura.
    Donnithorne KJ, Atkinson TP, Hinze CH, Nogueira JB, Saeed SA, Askenazi DJ, Beukelman T, Cron RQ.
    J Pediatr; 2009 Jul 07; 155(1):136-9. PubMed ID: 19559299
    [Abstract] [Full Text] [Related]

  • 13. Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome?
    Smith GC.
    Pediatr Nephrol; 2007 Jun 07; 22(6):893-8. PubMed ID: 17310362
    [Abstract] [Full Text] [Related]

  • 14. Treatment of childhood steroid-resistant idiopathic nephrotic syndrome.
    Niaudet P, Gagnadoux MF, Broyer M.
    Adv Nephrol Necker Hosp; 1998 Jun 07; 28():43-61. PubMed ID: 9889985
    [No Abstract] [Full Text] [Related]

  • 15. New insights into the pathophysiology of idiopathic nephrotic syndrome.
    Bruneau S, Dantal J.
    Clin Immunol; 2009 Oct 07; 133(1):13-21. PubMed ID: 19410518
    [Abstract] [Full Text] [Related]

  • 16. Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome.
    Spika JS, Halsey NA, Fish AJ, Lum GM, Lauer BA, Schiffman G, Giebink GS.
    Pediatrics; 1982 Feb 07; 69(2):219-23. PubMed ID: 7058096
    [Abstract] [Full Text] [Related]

  • 17. Rituximab treatment for resistant antiphospholipid syndrome.
    Rubenstein E, Arkfeld DG, Metyas S, Shinada S, Ehresmann S, Liebman HA.
    J Rheumatol; 2006 Feb 07; 33(2):355-7. PubMed ID: 16465669
    [Abstract] [Full Text] [Related]

  • 18. [Histological studies and progression characteristics in 56 children with corticosteroid-resistant nephrotic syndrome].
    Gaboardi F, Gennari L, Edefonti A, Chiccoli C, Principi N.
    Minerva Pediatr; 1975 Jan 14; 27(1):16-28. PubMed ID: 1223631
    [No Abstract] [Full Text] [Related]

  • 19. Rituximab in steroid-dependent nephrotic syndrome.
    El Koumi M.
    Iran J Kidney Dis; 2013 Nov 14; 7(6):502-6. PubMed ID: 24241100
    [Abstract] [Full Text] [Related]

  • 20. [Management of severe idiopathic nephrotic syndrome in children].
    Bensman A.
    Bull Acad Natl Med; 2009 Nov 14; 193(8):1727-33; discussion 1734. PubMed ID: 20669537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.